CJC-1295 / IpamorelinCJC-1295 / Ipamorelin
$119.99
This product is intended for laboratory research use only. Not for human consumption or clinical use.
Overview
CJC-1295 (no DAC) and Ipamorelin is a research peptide blend combining two mechanistically distinct secretagogues that act synergistically on the growth hormone axis. CJC-1295 (Mod GRF 1–29) targets GHRH receptors, stimulating cAMP/PKA-mediated GH synthesis, while Ipamorelin binds the ghrelin receptor (GHS-R1a), activating Gq/11-linked calcium signaling pathways. Together, they serve as a model for studying peptide-induced GH pulsatility, receptor cross-talk, and hypothalamic–pituitary regulation in controlled experimental systems.
This product is a laboratory-formulated peptide blend consisting of CJC-1295 (No DAC; Modified GRF (1–29)) and Ipamorelin. The blend is supplied exclusively for research use to support mechanistic investigation of growth hormone axis signaling through coordinated activation of GHRHR and GHSR-1a in preclinical experimental systems. CJC-1295 (No DAC) is a synthetic GHRH analog derived from the N-terminal 29–amino-acid sequence of endogenous GHRH, engineered to increase resistance to proteolytic degradation while retaining high affinity for the GHRH receptor. Ipamorelin is a synthetic pentapeptide and a highly selective agonist of the ghrelin/growth hormone secretagogue receptor (GHSR-1a), used in laboratory studies to evaluate receptor-specific signaling with minimal off-target pituitary hormone activation.
Quality & Testing
Each batch is tested and documented to support research transparency and consistent research workflows. Certificates of Analysis (COAs) are provided by batch so researchers can reference the specific analytical results tied to the exact lot associated with their order. This supports clearer recordkeeping, improved comparability across experiments, and stronger traceability over time.
Quality documentation is designed to help researchers confirm key batch attributes before use, including identity verification and purity results using established analytical methods such as HPLC and mass spectrometry where applicable. COAs typically include the batch identifier, test methods performed, and reported results, allowing researchers to maintain complete lab records and improve reproducibility across protocols and study timelines.
Batch Transparency
Every unit is associated with a batch identifier to support traceability and reproducible research. Batch tracking helps researchers link their materials to the exact analytical documentation for that production lot, which is important when comparing results across different runs, timelines, or study conditions. This also makes it easier to maintain clean lab records and verify continuity when repeating protocols.
Certificates of Analysis (COAs) are organized by batch so you can reference the specific results tied to the batch you received. To use this system, locate the batch number on the vial label or packaging and match it to the corresponding COA for that SKU. Save the COA and batch number alongside your research notes so your documentation stays complete and auditable over time.
Specifications
Every Batch Verified.
HPLC Analysis
High-Performance Liquid Chromatography confirms peptide purity and identity.
Mass Spectrometry
Molecular weight verification through advanced mass spec analysis.
Endotoxin Testing
LAL assay confirms endotoxin levels meet strict specifications.
Research Use Compliance
All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Native Peptides is a chemical supplier. Native Peptides is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Native Peptides is not an outsourcing facility as defined under Section 503B of the Federal Food, Drug, and Cosmetic Act.
All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.

